Jesse A. Berlin
Johnson & Johnson Pharmaceutical Research and Development
37 Papers
4.8K Citations
Jesse A. Berlin is an academic researcher from Johnson & Johnson Pharmaceutical Research and Development. The author has contributed to research in topics: Medicine & Odds ratio. The author has an hindex of 21, co-authored 37 publications. Previous affiliations of Jesse A. Berlin include Hospital of the University of Pennsylvania & University of Medicine and Dentistry of New Jersey.
Chat about Author
Papers
Inclusion of women in clinical trials.
TL;DR: It is concluded that the controversy over the inclusion of women in clinical trials probably stems, in part, from theoretical concerns about gender differences in treatment effects and by legitimate fears of exposing fetuses to investigational drugs.
N-of-1 clinical trials should be incorporated into clinical practice.
TL;DR: N-of-1 clinical trials have the potential to contribute to individual patient management and to the accrual of important information about populations and incorporation into clinical practice will require creative thinking so as to maintain rigor without excessive disruption of routine care.
23
Risk of breast cancer associated with short-term use of oral contraceptives.
Suzanne G. Folger,Polly A. Marchbanks,Jill A. McDonald,Leslie Bernstein,Giske Ursin,Giske Ursin,Jesse A. Berlin,Janet R. Daling,Sandra A. Norman,Brian L. Strom,Linda K. Weiss,Michael S. Simon,Ronald T. Burkman,Kathleen E. Malone,Robert Spirtas +14 more
TL;DR: Estimating breast cancer risk associated with short-term (<6 months) oral contraceptive use and exploring variation in estimates by use characteristics and medical, menstrual, and reproductive history found associations were more pronounced in women with non-contraceptive reasons for use and underlying risk factors for breast cancer.
23
Registration of Observational Studies: perspectives from an industry-based epidemiology group.
TL;DR: This commentary proposes that a compromise can be reached on which observation should be registered based on study design and study intent, and suggests that the registration of observational studies remains controversial.
18